Recombinant PDCD1 (Pembrolizumab Biosimilar) anticorps

N° du produit ABIN7581619

L’anticorps Human Monoclonal anti-PDCD1 (Pembrolizumab Biosimilar) a été validé pour FACS, ELISA, BLI, Func et SPR. Il convient pour détecter PDCD1 (Pembrolizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant PDCD1 (Pembrolizumab Biosimilar) anticorps (ABIN7581619)

Antigène: PDCD1 (Pembrolizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp PDCD1 (Pembrolizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-PDCD1 (Pembrolizumab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)

Séquence: QVQLVQSGVE VKKPGASVKV SCKASGYTFT NYYMYWVRQA PGQGLEWMGG INPSNGGTNF NEKFKNRVTL TTDSSTTTAY MELKSLQFDD TAVYYCARRD YRFDMGFDYW GQGTTVTVSS ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPPCP APEFLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG NVFSCSVMHE ALHNHYTQKS LSLSLGK,EIVLTQSPAT LSLSPGERAT LSCRASKGVS TSGYSYLHWY QQKPGQAPRL LIYLASYLES GVPARFSGSG SGTDFTLTIS SLEPEDFAVY YCQHSRDLPL TFGGGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC

Attributs du produit: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Pureté: >95 %

Isotype: IgG4 S228P

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: PD-1 inhibitors

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur PDCD1 (Pembrolizumab Biosimilar)

Antigène: PDCD1 (Pembrolizumab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 145.5 kDa

UniProt: Q15116